Answer
Lenvatinib Eisai monotherapy is indicated for adults with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.
Sources for this answer
- Lenvatinib Eisai 4mg hard capsulesEisai Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 32Document updated
Sources checked